Andrew is a member of the Life Sciences Health Industry Group in Reed Smith’s Washington, D.C. office, where he assists on an array of healthcare litigation and regulatory matters. His practice focuses primarily on compliance, investigations, and litigation relating to the Anti-Kickback Statute, the Stark Law, and state and federal false claims acts on behalf of national retail pharmacy chains, pharmaceutical and medical-device manufacturers, and EHR vendors. Andrew is especially interested in the legal implications of new technologies for life sciences and health care companies.